Navigation Links
Tests may help answer questions about GMOs and allergies

The potential of genetically engineered foods to cause allergic reactions in humans is a big reason for opposition to such crops. Although protocols are in place to ask questions about the allergy-causing possibilities, there has been no test that offers definitive answers.

But all of that could change as a Michigan State University researcher has developed the first animal model to test whether genetically engineered foods could cause human allergic reactions. Venu Gangur, MSU assistant professor of food science and human nutrition, has received a $447,000 grant from the Environmental Protection Agency to validate the test.

Genetically engineered crops are created by inserting a protein from a different organism into the original crop's genome. This is usually done to create a plant that is more resistant to insects or diseases.

The Food and Agriculture Organization within the World Health Organization has a structured approach to determining whether genetically engineered foods cause allergies, according to Gangur, who also is a faculty member in the National Food Safety and Toxicology Center. "But it has a major flaw. A critical question in that process asks, 'Does the protein cause an allergic reaction in animals?' The problem is that there has been no good animal model available to test this."

Gangur and students in his lab have developed a mouse model ?the first of its kind ?to test the allergy-causing potential of genetically engineered foods. He'll use the EPA grant to examine whether the model works on a variety of proteins. If successfully validated, the testing could be available commercially in about five years.

Perhaps the best known case of a genetically engineered crop potentially causing allergies was StarLink corn. Created by Aventis in 1996, StarLink contained the cry9C protein from a common soil bacterium, a strain of Bacillus thuringiensis. The cry9C protein protected the corn from several types of corn bor
'"/>

Source:American Society for Biochemistry and Molecular Biology


Page: 1 2

Related biology news :

1. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
2. Tests for face-blindness reveal disorder may not be so rare
3. Scientists seek answers on what activates deadly anthrax spores
4. Climate experts search for answers in the oceans
5. Finding an answer to Darwins Dilemma
6. Plants give up answers in the war on bacteria
7. One signal elicits thousands of answers
8. Are genomic technologies the answer to world hunger?
9. Does God answer prayer? ASU research says yes
10. Why arent humans furry? Stone-Age moms could be the answer
11. Trusting your instincts leads you to the right answer
Post Your Comments:
(Date:7/25/2008)...e basic science discoveries into the clinical aren...rs at the Medical College of Wisconsin, in Milwauk...fied reasons why clinical science grant applicati...science grant applications to the NIH. The finding...n Journal of Medicine . , In collaboration with ...
(Date:7/25/2008)...try specialists from 22 countries are sharing the ..., such as mustard, radish, or rapeseed, to manage ...iofumigation. ," Brassica plants naturally rele...rincipally isothiocyanates (ITCs), which most peop... or horseradish," says CSIRO,s Dr John Kirkegaard....
(Date:7/25/2008)...en, can potentially contain a naturally occurring ...o public health according to a review paper publis...f the Science of Food and Agriculture (JSFA). , ...green, affected area is enough to eliminate most o...suggests that the levels of GA in potatoes can be ...
(Date:7/24/2008)... by Massachusetts General Hospital (MGH) investiga... research and medicine a robust method for genera...DNA sequences for inactivation or repair. In the...s describe an efficient, publicly available method...s), which can be used to induce specific genomic m...
Breaking Biology News(10 mins):New study spotlights National Institutes of Health grant outcomes for clinical research 2Consortium develops new method enabling routine targeted gene modification 2ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 1ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 2ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 3ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 4ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 5ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 6ADVENTRX Pharmaceuticals Inc Reports Fourth Quarter and Full Year 2007 Financial Results 3948 7FDA Panel Supports Anemia Drugs for Cancer Patients 14341 1FDA Panel Supports Anemia Drugs for Cancer Patients 14341 2FDA Panel Supports Anemia Drugs for Cancer Patients 14341 3SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 1SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 2SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 3SURGEX 28TM 29 Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard 14337 4ViroPharma to Present at the Cowen 26 Company 28th Annual Healthcare Conference 3947 1
...gets wiser, so do the bugs. The rates of drug-resi... and in the hospital have been increasing steadily...the June 15 issue of Clinical Infectious Diseases,...rganisms has become a problem due in part to inapp...hese drug-resistant "superbugs" can infect people ...
...scientist at Washington University in St. Louis ha...nome of a worm and has found 150 genes that were m...r, using the software, he and his colleagues have ...ing 1119 more genes. , Michael Brent, Ph.D., Washi... engineering, used his unique software, TWINSCAN, ...
...impact factors prove that BioMed Central,s Open Ac... cited. Journals published by BioMed Central have ...th equivalent subscription titles, it was announce... specialty. The high impact factors for these jour..., and are fast becoming the place for authors to s...
...s are active protein polymers critical to the stru...l division. In a living cell their growing ends co...y of polymerization and depolymerization, like the...ly as "dynamic instability," this ongoing rapid gr...of microtubules in the cell. , For the first time,...
Other Biology News:Two studies document rise of superbugs in the environment 2Two studies document rise of superbugs in the environment 3Program finds lost genes in nematode genome 2Program finds lost genes in nematode genome 3Open Access journals get impressive impact factors 2The making and breaking of microtubules 2The making and breaking of microtubules 3The making and breaking of microtubules 4The making and breaking of microtubules 5
(Date:7/24/2008)...ly 24 /- The Global Probiotics Counci... DANONE and Yakult Honsha,Co., Ltd., announced the...,Investigator Grant for Probiotics Research (YIGPR...g rising stars who will continue to contribute to,...esearch in the United,States., Ajay S. Gulati, MD...
(Date:7/24/2008)..., Calif., July 24 /- Poniar...rmaceutical company focused,on oncology, today ann...uss,the Company,s second quarter results and provi...clinical development plan for picoplatin, the,Comp..., chairman and chief,executive officer, Ronald A. ...
(Date:7/24/2008)...y 24 /- Cara Therapeutics, Inc.,annou...additional funding,to its original $24 million Ser...ound was led by new investor, Devon Park Bioventur...vations. Previous investors participating,in the r...shi International,Corporation and Wistar Morris. I...
(Date:7/24/2008)...uly 24 /- Sagent Pharmaceuticals, Inc...ny, today announced that it,has launched ceftazidi...rum, beta-lactam antibiotic. Sagent will offer cef...macy bulk package vials. According to,IMS data, 20...ates were,approximately $45.7 million., "Sagent i...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...r network Silicon Pastures will invest $195,000 ...oping a next-generation credit card processor that...usual for Wisconsin-based investors to look beyond...director of Silicon Pastures, said this investment...right place. , ,"Our investors traditionally pref...
... of a U.S. Senate debate on stem cell policy just ... Senators to overturn President Bush,s ban on fe...,During a morning visit to the West Salem home of ...n Adam has diabetes, Doyle again used the backdrop...stem cell research to plead his case for a less re...
...n of NeoClone secured equity money early this ye...mitment to his investors to take a more aggressive...a seven-year-old manufacturer of monoclonal antibo...base organically, through word-of mouth, and by us...he had to do more to maximize his relatively small...
...the medical device developer that has secured $42 ...les of its precision radiation therapy technology ...in-Madison researchers, is riding high. , ,So hig..., ,The company, which recently completed an $8.2 m...production and test volumes, has no immediate need...
Other Biology Technology:Doyle urges Senate to loosen stem cell restrictions 2Doyle urges Senate to loosen stem cell restrictions 3Doyle urges Senate to loosen stem cell restrictions 4Can sales outsourcing grow Wisconsin biotechs? 2Can sales outsourcing grow Wisconsin biotechs? 3Cash-rich TomoTherapy has no plans for IPO 2Cash-rich TomoTherapy has no plans for IPO 3Cash-rich TomoTherapy has no plans for IPO 4
Lingo-1 (K-13)
Rabbit polyclonal to Atrophin 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 1150 to the C-terminus of Human Atrophin 1.(No
Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays.
Complexin-1/2 (FL-134)
Biology Products: